What is Dishman Carbogen Amcis Ltd (DCAL) share price return in the past 10 years?

Data is not available for this company

What is the share price of Dishman Carbogen Amcis Ltd (DCAL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Dishman Carbogen Amcis Ltd (DCAL) on 24-Jun-2026 16:59:59 at 16:59 is 174.05.

What is the P/E ratio of Dishman Carbogen Amcis?

The latest standalone P/E ratio of Dishman Carbogen Amcis as of 24-Jun-2026 is 0.00.

What is the P/B ratio of Dishman Carbogen Amcis Ltd (DCAL)?

The latest standalone P/B ratio of Dishman Carbogen Amcis Ltd (DCAL) as of 24-Jun-2026 is 0.70.

What is the 52-week high and low of Dishman Carbogen Amcis Ltd (DCAL)?

The 52-week high of Dishman Carbogen Amcis Ltd (DCAL) is Rs. 321.15 and the 52-week low is Rs. 129.00.

Dishman Carbogen Amcis Ltd (DCAL) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Dishman Carbogen Amcis Ltd (DCAL)
Brand: Dishman Carbogen Amcis

Dishman Carbogen Amcis Ltd (DCAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540701 NSE: DCAL Pharmaceuticals & Drugs | Small Cap | Dishman Carbogen Amc Share Price

Dishman Carbogen Amcis Ltd (DCAL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540701 NSE: DCAL Pharmaceuticals & Drugs | Small Cap | Dishman Carbogen Amc Share Price

Key Metrics

Valuation Multiples

Market Cap

₹2,729 Cr.

Current Price

₹174.1

52-Week Low / High

₹129 / 321

TTM EPS

₹6.2

TTM Sales

₹2,932 Cr.

Book Value per Share

₹425.9

P/E Ratio

28.00

Industry PE

48.5

Price to Book (P/B)

0.41

Lower than its 5-year historical median

Price to Sales (P/S)

0.93

Lower than its 5-year historical median

EV/EBITDA

7.26

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

0.06%

Underperforms industry median

Return on Capital Employed (ROCE)

2.31%

Underperforms industry median

Return on Assets (ROA)

0.03%

Operating Profit Margin

16.6%

Net Profit Margin

0.12%

Gross Profit Margin

12.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

3.66%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

66.61%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

59.32%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹6,646 Cr.

Equity

₹31.4 Cr.

Face Value

₹2

All Time Low / High

₹46.45 / 396.55

Dishman Carbogen Amcis stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Dishman Carbogen Amcis Ltd a good quality company?

Dishman Carbogen Amcis Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Dishman Carbogen Amcis Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Dishman Carbogen Amcis Ltd vs industry peers?

Dishman Carbogen Amcis Ltd revenue CAGR is 5.82%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Dishman Carbogen Amcis Ltd?

Promoters hold 59.32% of the Dishman Carbogen Amcis Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Dishman Carbogen Amcis Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 0.49% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	4.6%	4.7%	5.8%	3.9%	-0.3%	0.8%	0.4%	-0%	2.3%	-
Value Creation Index ⓘ	NA	-0.7	-0.7	-0.6	-0.7	-1.0	-1.0	-1.0	-1.0	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	0	1,714	1,695	2,059	2,044	1,912	2,141	2,413	2,616	2,712	2,932
Sales YoY Gr.	-	NA	-1.1%	21.5%	-0.7%	-6.4%	12%	12.7%	8.4%	3.7%	-
Adj EPS ⓘ	0	0	10.2	13.8	10.9	-8.9	1.9	2.7	-8.9	1.5	6.2
YoY Gr.	-	NA	NA	35.2%	-21.2%	-181.9%	NA	42.5%	-435.5%	NA	-
BVPS (₹) ⓘ	0	0	316.4	333.3	364.3	363.5	353.9	370.5	358.9	371.9	425.9
Adj Net Profit ⓘ	0	159	165	223	171	-140	29.2	41.5	-139	23.1	98
Cash Flow from Ops. ⓘ	0	303	226	282	585	513	355	266	384	375	-
Debt/CF from Ops. ⓘ	0	3.1	4.8	3.7	1.8	2.3	4	6.9	5.1	5.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	5.8%	8.2%	3.7%
Adj EPS ⓘ	NA	-33%	-7.5%	NA
BVPSⓘ	NA	0.4%	1.7%	3.6%
Share Price	-	-2.6%	7.9%	-30.1%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.3	3.3	4.3	3.1	-2.5	0.5	0.7	-2.4	0.4	1.6
Op. Profit Mgn % ⓘ	26.6	26.9	27.9	25.2	15.2	15.5	16	10.7	16.6	19.3
Net Profit Mgn % ⓘ	8.4	9.8	10.9	8.4	-7.3	1.4	1.7	-5.3	0.9	3.3
Debt to Equity ⓘ	238.6	0.2	0.2	0.2	0.2	0.3	0.3	0.4	0.4	0.2
Working Cap Days ⓘ	0	339	308	332	346	279	254	241	239	159
Cash Conv. Cycle ⓘ	0	139	127	142	155	141	156	157	162	22

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	1,714	1,695	2,059	2,044	1,912	2,141	2,413	2,616	2,712
Operating Expenses ⓘ +	1,260	1,257	1,507	1,546	1,638	1,815	2,081	2,352	2,272
Manufacturing Costs	148	132	171	178	160	207	259	314	259
Material Costs	329	337	404	459	468	447	517	597	502
Employee Cost	596	625	715	762	873	981	1,030	1,208	1,294
Other Costs ⓘ	187	162	217	147	137	179	275	233	218
Operating Profit ⓘ	453	438	552	498	274	326	332	264	440
Operating Profit Margin (%)	26.5%	25.8%	26.8%	24.3%	14.3%	15.2%	13.8%	10.1%	16.2%
Other Income ⓘ +	26	53	54	44	39	49	28	51	51
Exceptional Items ⓘ	0	0	0	0	-22	-15	-48	-6	-18
Interest ⓘ	49	49	57	62	48	57	86	120	159
Depreciation ⓘ	214	211	240	283	308	308	281	311	294
Profit Before Tax ⓘ	216	231	309	197	-65	-4	-55	-122	19
Tax ⓘ	71	76	98	39	100	-22	-25	31	16
Profit After Tax	145	155	210	159	-165	18	-30	-153	3
PAT Margin (%)	8.5%	9.1%	10.2%	7.8%	-8.6%	0.8%	-1.2%	-5.9%	0.1%
Adjusted EPS (₹)	0.0	9.6	13.0	10.1	-10.5	1.2	-1.9	-9.8	0.2
Dividend Payout Ratio (%)	0%	0%	1.50%	0%	0%	0%	0%	0%	0%

Valuation of Dishman Carbogen Amc - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4	5,107	5,379	5,715	5,699	5,549	5,810	5,628	5,832
Share Capital ⓘ	0	32	32	31	31	31	31	31	31
Reserves ⓘ	4	5,075	5,347	5,684	5,667	5,518	5,778	5,596	5,800
Debt +	845	918	883	930	1,046	1,255	1,727	1,866	1,805
Long Term Debt	460	525	362	241	504	762	1,047	246	1,149
Short Term Debt	385	393	520	688	542	493	681	1,620	655
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	86	186	195	284	169	193	220	244	231
Others Liabilities ⓘ	5,640	957	864	1,265	1,441	1,637	1,683	1,833	2,120
Total Liabilities ⓘ	6,574	7,169	7,321	8,193	8,356	8,634	9,439	9,571	9,986
Fixed Assets
Net Fixed Assets ⓘ +	4,847	5,061	5,092	5,673	5,693	5,768	6,183	6,720	7,051
Gross Block	6,187	6,621	6,897	7,891	8,155	8,633	9,458	10,308	10,545
Accumulated Depreciation	1,340	1,560	1,805	2,218	2,462	2,865	3,275	3,588	3,495
CWIP ⓘ	133	151	175	234	486	780	1,043	646	467
Investments ⓘ	40	196	167	191	172	324	249	102	97
Inventories	427	485	549	581	516	645	804	883	900
Trade Receivables	286	444	445	577	421	473	590	484	665
Cash Equivalents	87	69	96	161	308	172	189	413	507
Others Assets ⓘ	755	764	796	776	760	472	381	322	299
Total Assets ⓘ	6,574	7,169	7,321	8,193	8,356	8,634	9,439	9,571	9,986

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	303	226	282	585	513	355	266	379	375
PBT ⓘ	216	231	309	197	-65	-4	-55	-122	19
Adjustment ⓘ	232	235	277	330	313	325	392	377	467
Changes in Working Capital ⓘ	-29	-206	-174	132	316	90	-38	144	-81
Tax Paid ⓘ	-116	-34	-130	-74	-51	-56	-34	-19	-30
Cash Flow From Investing Activity ⓘ +	-142	-297	-169	-442	-380	-619	-494	-230	-192
Capex	-139	-205	-308	-409	-365	-455	-618	-303	-215
Net Investments	3	-148	68	-28	21	-171	104	150	-1
Others ⓘ	-6	56	71	-6	-36	8	21	-76	24
Cash Flow From Financing Activity ⓘ +	-137	78	-102	-98	-11	130	250	-22	-102
Net Proceeds from Shares ⓘ	-1	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-98	118	-172	-154	169	282	167	50	194
Interest Paid ⓘ	-52	-49	-57	-61	-53	-60	-73	-99	-151
Dividend Paid ⓘ	-19	0	0	-3	0	0	0	0	0
Others ⓘ	33	8	127	121	-127	-92	156	26	-145
Net Cash Flow ⓘ	23	7	11	46	122	-133	22	128	81

Financial Ratio

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3654.02	6.05	4.01	2.86	-2.89	0.32	-0.52	-2.68	0.06
ROCE (%)	4.6	4.67	5.79	3.93	-0.26	0.76	0.43	-0.03	2.31
Asset Turnover Ratio	0.26	0.25	0.28	0.26	0.23	0.25	0.27	0.28	0.28
PAT to CFO Conversion(x)	2.09	1.46	1.34	3.68	N/A	19.72	N/A	N/A	125
Working Capital Days
Receivable Days	60.80	78.60	78.90	91.30	95.30	76.20	80.40	75	77.40
Inventory Days	90.90	98.10	91.60	100.90	104.70	99	109.60	117.70	120
Payable Days	94.90	147.10	172	190.20	176.50	147.90	145.90	141.80	172.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dishman Carbogen Amcis Ltd FAQs

The current trading price of Dishman Carbogen Amc on 24-Jun-2026 16:59 is ₹174.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Dishman Carbogen Amc stood at ₹2,728.8 Cr

The latest P/E ratio of Dishman Carbogen Amc as of 23-Jun-2026 is 0.00.

The latest P/B ratio of Dishman Carbogen Amc as of 23-Jun-2026 is 0.70.

The 52-week high of Dishman Carbogen Amc is ₹321.1 and the 52-week low is ₹129.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dishman Carbogen Amc is ₹232 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dishman Carbogen Amcis Ltd is a below average quality company.

The key valuation ratios of Dishman Carbogen Amcis Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dishman Carbogen Amcis Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Dishman Carbogen Amcis Ltd

Incorporated in 1983, Dishman Carbogen Amcis Limited (DCAL) started out as a manufacturer of quaternary ammonium and phosphate compounds. Having ventured into the CRAMS space in India, the company soon became one of the fastest growing companies. Today, the company is a leading global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up, and manufacturing services.

The company aids drug innovators for development and process optimization for novel drug molecules in various stages of the development process. Once the innovative molecules are approved, the company further explore the possibility of large scale commercial supply tie-ups. The company is generating a healthy pipeline of contract manufacturing opportunities commensurate to the growing revenue base of manufacturing. Its robust business model is capable of sustaining growth, with CRAMS being the focal point of all its strategic efforts.

Business area of the company

The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Products and services

CRAMS
Vitamin D & Analogues
Disinfectants
Highly Potent API Supply
Niche Generic API
Speciality Chemicals

History and Milestones

1983: Incorporation of Dishman Pharmaceutical and Chemicals Limited.
1989: Commencing production of Phase Transfer Catalysts at Naroda facility.
1995: Entered into a JV with Schutz & Co. for manufacturing Chlorhexidine and Derivatives for European market.
1996: Commencement of Bavla facility for Bulk Intermediates.
2001: First commercial contract manufacturing agreement signed with a major western pharmaceutical company.
2004: Came out with an IPO on Indian stock exchanges.
2005: Acquisition of Synprotec - DCR (now known as CARBOGEN AMCIS Ltd, UK).
2006: Acquisition of CARBOGEN AMCIS - a Swiss based CRAMS player.
2007: Acquisition of Solvay Pharmaceuticals’ Vitamins and Chemicals business (now known as CARBOGEN AMCIS BV).
2010: Commenced Dishman Shanghai manufacturing facility.
2012: Acquisition of Riom (France) - CARBOGEN AMCIS SAS.
2014: Acquisition of Vionnaz (CH) site - CARBOGEN AMCIS.
2017: Change of name of the parent to Dishman Carbogen Amcis Limited, reinforcing the synergies between Dishman and Carbogen Amcis brands.
2020: Global Reorganization of Roles and Responsibilities of the Management Team.

Dishman Carbogen Amcis Ltd (DCAL)

Dishman Carbogen Amcis Ltd (DCAL)

Dishman Carbogen Amcis stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Dishman Carbogen Amc - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dishman Carbogen Amcis Ltd FAQs

About Dishman Carbogen Amcis Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Dishman Carbogen Amcis Ltd (DCAL)

Dishman Carbogen Amcis Ltd (DCAL)

Dishman Carbogen Amcis stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Dishman Carbogen Amc - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dishman Carbogen Amcis Ltd FAQs

What is the share price of Dishman Carbogen Amc?

What is the market cap of Dishman Carbogen Amc?

What is the P/E ratio of Dishman Carbogen Amc?

What is the P/B ratio of Dishman Carbogen Amc?

What is the 52-week high and low of Dishman Carbogen Amc?

What is the TTM revenue of Dishman Carbogen Amc?

Is Dishman Carbogen Amcis Ltd a good quality company?

Is Dishman Carbogen Amcis Ltd undervalued or overvalued?

Is Dishman Carbogen Amcis Ltd a good buy now?

About Dishman Carbogen Amcis Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.